首页> 外文OA文献 >A post-marketing study on interferon ß 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

【2h】

A post-marketing study on interferon ß 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

机译：复发性多发性硬化症中ß1b和1a干扰素治疗的售后研究：辍学患者和治疗患者的反应不同

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objectives: To evaluate the effectiveness of these agents on the basis of clinical experience in northern Italian multiple sclerosis centres.

机译：目的：根据意大利北部多发性硬化症中心的临床经验，评估这些药物的有效性。

著录项

作者
Milanese, C; La Mantia, L; Palumbo, R; Martinelli, V; Murialdo, A; Zaffaroni, M; Caputo, D; Capra, R; Bergamaschi, R;
展开▼
作者单位

展开▼
年度 2003
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. [J] . Milanese C, La Mantia L, Palumbo R, Journal of Neurology, Neurosurgery and Psychiatry . 2003,第12期

机译：复发-缓解型多发性硬化症中干扰素beta 1b和1a治疗的上市后研究：辍学患者和治疗患者的反应不同。
2. Effects of interferon β-1a and interferon β-1b monotherapies on selected serum cytokines and nitrite levels in patients with relapsing-remitting multiple sclerosis: A 3-year longitudinal study [J] . St?pieńA., ChalimoniukM., Lubina-Da?browskaN., Neuroimmunomodulation . 2013,第4期

机译：干扰素β-1a和干扰素β-1b单一疗法对复发缓解型多发性硬化症患者血清细胞因子和亚硝酸盐水平的影响：一项为期三年的纵向研究
3. Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: Results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II) [J] . PattiF., AmatoM.P., TrojanoM., Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2012,第7期

机译：患有皮下注射干扰素β-1a的轻度残疾复发缓解型多发性硬化症患者社会功能的纵向变化：COGIMUS（多发性硬化症认知功能减退）研究的结果（II）
4. HCV-related Factors but not HIV-Related Factors at Baseline Predict the Response to Treatment With Peginterferon alfa-2a (40KD) (PEGASYS) Plus Ribavirin (COPEGUS) in Patients With HCV/HIV Co-infection: Predictor Analysis From the APRICOT Study [C] . D. Cooper, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：HCV相关因素但基线上没有艾滋病毒相关因素预测与HCV / HIV共感染患者的Peginterferon Alfa-2a（40kd）（Pegasys）（Pegasys）加利巴韦林（Copegus）对治疗的反应：来自杏研究的预测因素分析
5. Cost-Effectiveness of Oral Agents in Relapsing-Remitting Multiple Sclerosis Compared to Interferon-Based Therapy in Saudi Arabia [D] . Alskaabi, May. 2017

机译：沙特阿拉伯口服药物在复发缓解型多发性硬化症中的成本效果与基于干扰素的疗法相比
6. A post-marketing study on interferon ß 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients [O] . C Milanese, L La Mantia, R Palumbo, 2003

机译：复发性多发性硬化症中干扰素ß1b和1a治疗的售后研究：辍学患者和治疗患者的反应不同
7. Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a [O] . Flechter, Shlomo, Klein, Tirza, Pollak, Lea 2011

机译：组织相容性基因对干扰素β-1a治疗复发缓解型多发性硬化患者疾病易感性和治疗反应的影响

A post-marketing study on interferon ß 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅